With specialist IP providers offering post-M&A services at lower cost than traditional law firms, have clients been overspending in the past? Melissa Pillote on behalf of Dennemeyer reports.
Latest asia-pacific news
India-based Initiative for Medicines, Access & Knowledge has filed four patent challenges against patents covering hepatitis C drugs in a bid to ensure access to affordable treatment.
- Australia's drug prices to drop by up to 50% 06-09-2016
- Sanofi and Genzyme recover domain at WIPO 16-11-2016